From: Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis
 | Model 1 | Model 2 | ||
---|---|---|---|---|
EDSS | EDSS progression/year | |||
(n=100, R2=0.72) | (n=100, R2=0.21) | |||
Baseline Predictor | Regression coefficient ± SE | p-value | Regression coefficient ± SE | p-value |
Intercept | 2.8 ± 3.3 | 0.39 | 0.33 ± 0.59 | 0.58 |
Age (yrs) | −0.0033 ± 0.014 | 0.81 | −0.00001 ± 0.0025 | 0.99 |
Height (cm) | −0.015 ± 0.021 | 0.48 | −0.0015 ± 0.0038 | 0.69 |
Weight (kg) | −0.0059 ± 0.0098 | 0.55 | −0.0015 ± 0.0018 | 0.39 |
Sex (1= male) | 0.090 ± 0.31 | 0.77 | 0.028 ± 0.056 | 0.62 |
Laterality (1=left) | −0.066 ± 0.38 | 0.86 | −0.046 ± 0.070 | 0.52 |
Phenotype (1 = SP or PP) | 0.39 ± 0.46 | 0.40 | 0.010 ± 0.083 | 0.90 |
Disease duration (yrs) | 0.0054 ± 0.016 | 0.73 | 0.0027 ± 0.0029 | 0.35 |
Follow-up duration (yrs) | 0.036 ± 0.046 | 0.43 | NA | NA |
DMT (1 = yes) | 0.18 ± 0.37 | 0.63 | 0.057 ± 0.066 | 0.39 |
EDSS | 0.75 ± 0.13 | <0.0001 | −0.035 ± 0.025 | 0.16 |
EP Score | 0.082 ± 0.018 | <0.0001 | 0.012 ± 0.0034 | 0.0006 |